Bronchopulmonary dysplasia as a risk factor for asthma in school children and adolescents: A systematic review

S Pérez Tarazona1, P Solano Galán2, E Bartoll Alguacil2

  • 1Division of Neonatology, University & Polytechnic Hospital La Fe, Valencia, Spain.

Insights

Bronchopulmonary dysplasia (BPD) is a chronic lung disease in premature infants. This review found no strong evidence that BPD independently increases asthma risk in children and adolescents beyond prematurity itself.

Area of Science:

  • Pediatric Pulmonology
  • Neonatology
  • Epidemiology

Background:

  • Bronchopulmonary dysplasia (BPD) is a prevalent chronic lung disease in extremely premature infants.
  • Prematurity is a known risk factor for developing asthma in later childhood.
  • The independent contribution of BPD to asthma risk requires further investigation.

Purpose of the Study:

  • To systematically review existing literature on the association between bronchopulmonary dysplasia (BPD) and asthma in school-aged children and adolescents.
  • To determine if BPD confers an additional risk for asthma beyond prematurity.

Main Methods:

  • A systematic literature search was conducted in MEDLINE and EMBASE databases.
  • Studies published between January 2000 and August 2016 were included.
  • The review analyzed 17 studies involving 7433 patients.

Main Results:

  • Asthma prevalence was higher in children with a history of prematurity and BPD compared to those without BPD.
  • This difference in asthma prevalence did not consistently reach statistical significance across studies.
  • Significant heterogeneity in diagnostic criteria for BPD and asthma was noted, along with potential confounding factors.

Conclusions:

  • Current evidence does not support BPD as an independent risk factor for asthma in school-aged children and adolescents.
  • Further high-quality research with standardized diagnostic criteria for BPD and asthma is necessary.
  • Clarifying the independent role of BPD in pediatric asthma development remains an open question.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.9K